Operations, technology, quality, and digital transformation across biotechnology organizations.

Chief Technology Officer

Cell Culture Company | Shoreview, MN

Transitioned to CTO as part of a planned shift from a CEO-led structure to a shared executive leadership model following the company’s facility relocation. Held responsibility for enterprise technology strategy, quality, company-wide purchasing, and systems integration, building practical tools and systems that reduced manual work, improved decision-making, and connected quality, operations, and commercial execution.

• Built Python-based ERP automation for purchase order processing, cutting processing time by roughly 50%.
• Developed an AI-powered vendor pricing agent that compares negotiated pricing across suppliers and recommends purchasing adjustments based on actual patterns.
• Drove the roadmap and system integration design for the C3 Platform, an enterprise operations platform spanning multiple business functions.
• Automated board-level reporting by building tools that pull from disparate data sources, eliminating manual compilation.
• Restructured Google Ads from a misallocated configuration to a focused B2B search strategy targeting niche life-science buyers, significantly improving conversion volume, cost per conversion, and qualified lead quality year over year.
• Implemented offline conversion tracking and a Qualified Lead conversion action to enable meaningful ROI measurement for the first time.
• Deployed Claude Team (Anthropic AI) company-wide and managed adoption across the organization.

Chief Executive Officer

Cell Culture Company | Coon Rapids / Shoreview, MN

Led corporate strategy, P&L, and full operational and commercial accountability for a biologics CDMO. Redirected strategy, led the company through COVID-19 disruption and post-pandemic normalization, launched a third business division, and completed a full GMP facility relocation before the company transitioned from a CEO-led structure to a shared executive leadership model in January 2026.

• Grew revenue 61% and expanded gross margins by 27 percentage points in the first two years by refocusing strategy on the company's core Bioservices and Instruments divisions.
• Sustained profitability in five of six years as CEO; net income improved roughly 10x from the pre-CEO baseline at peak.
• Led a full GMP facility relocation from a 33,000 sq ft building in Coon Rapids to a 21,000 sq ft purpose-built space in Shoreview, on time and under a $1.3M budget, without disrupting customer operations or regulatory compliance.
• Launched Cell Line Development as a third business division, expanding commercial scope and service portfolio.
• Partnered with the Board of Directors and ownership on strategic priorities, resource allocation, and long-term planning.
• Reshaped organizational structure and leadership accountabilities to improve cross-functional execution and decision-making.

Operations and Quality Leadership

Cell Culture Company / Biovest International | Coon Rapids, MN

Progressed through increasingly broad leadership roles spanning quality, operations, and biologics manufacturing before being appointed CEO.

• Vice President of Operations: Led cross-functional operations supporting CDMO services and manufacturing, including planning, resource allocation, inventory, facilities, and operational execution.
• Vice President of Quality: Directed QMS and QA/QC functions and led the company to ISO 9001:2015 certification in under five months with zero findings, under budget and ahead of schedule.
• Earlier Quality Leadership: Built experience across cGMP quality systems, supplier qualification, CAPA, audits, equipment qualification, environmental monitoring, and OOS/OOT investigations.

Scientific and Laboratory Leadership

Pharmasan Labs | Vaccine CMC Quality Control | University of Toledo Health Science Campus

Built a scientific foundation spanning regulated clinical laboratory operations, immunological assay development, vaccine CMC quality control, and translational immunology research.